knowledge -WSS

knowledge

author：comprehensive 2025-09-02 08:22:44 - browse：417

Rising drug prices —Medicare coverage from STAT — Medicare on Friday released new details about how its new drug price negotiation program will work, just two months before it’s set to start. APStock

WASHINGTON — Medicare on Friday released new details about how its new drug price negotiation program will work, just two months before it’s set to start.

Medicare released an initial outline of how the program will work in March. Some parts, including the outline of how drugs would be selected for the negotiation process, were immediately final. The agency asked drug companies, patients, and other affected parties to weigh in on other parts about how the process would proceed, what factors would be considered, and how drugmakers would be held accountable.

Newsletters

Sign up for D.C. Diagnosis

An insider's guide to the politics and policies of health care

Please enter a valid email address. Privacy Policy

The negotiation process was created last August in Democrats’ drug pricing reform law, and Medicare is supposed to select the first 10 drugs that will be subject to negotiation by Sept. 1.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Ebola: Gilead Sciences antiviral shows promise as new treatment

explore

WSS

At JPM 2024, hospital systems pitch financial strength to investors

Allen Institute goes after foundational questions, CEO Costa says

Male and female sex labels in research insufficient, scientists say

Stories you might have missed in 2023: health, science, medicine

Male doctors called my cancer incurable. A female doctor showed it wasn't

Why depression after traumatic brain injury is distinct

focus

knowledge

Sign up for D.C. Diagnosis

focus

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Ascension's ugly legal battle over care for poor patients in Texas

Alkermes shareholders re

Readout LOUD podcast: ALS dilemma, first MASH drug, and more

Medical records are filled with copy

Male and female sex labels in research insufficient, scientists say

Bright Health sells Medicare Advantage business to Molina

Mayo Clinic partners with supercomputer AI firm Cerebras at JPM

How one medical school became remarkably diverse

Amid AI frenzy, a top HHS official's quest to create safeguards

entertainment

Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry

Readout LOUD podcast: ALS dilemma, first MASH drug, and more

Boston's new lab space is opening empty

FDA advisers back CAR

Nonprofit, backed by Microsoft, to certify AI tools in health care

Gene therapy denied for Afghan refugee whose father aided U.S.

explore

hotspot

focus

explore